Published in J Neuropsychiatry Clin Neurosci on January 01, 2012
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 3.96
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature (2005) 3.82
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry (2004) 3.64
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (2013) 3.26
Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry (2008) 2.86
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry (2006) 2.78
Limbic system surgery for treatment-refractory obsessive-compulsive disorder: a prospective long-term follow-up of 64 patients. J Neurosurg (2012) 2.66
Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65
Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys (2007) 2.33
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Human dorsal anterior cingulate cortex neurons mediate ongoing behavioural adaptation. Nature (2012) 2.16
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther (2006) 2.04
Alcohol teratogenesis: mechanisms of damage and strategies for intervention. Exp Biol Med (Maywood) (2005) 1.88
The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.87
Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol (2008) 1.86
Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging (2009) 1.84
Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J Appl Physiol (1985) (2002) 1.83
Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One (2011) 1.74
Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One (2008) 1.68
Neutrophil metabolic activity but not neutrophil sequestration reflects the development of pancreatitis-associated lung injury. Crit Care Med (2002) 1.67
Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum (2008) 1.61
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg (2008) 1.56
Hippocampal function in posttraumatic stress disorder. Hippocampus (2004) 1.54
Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics (2009) 1.53
Epidural cortical stimulation of the left dorsolateral prefrontal cortex for refractory major depressive disorder. Neurosurgery (2011) 1.52
A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. Neuroimage (2003) 1.49
Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One (2008) 1.48
FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer (2002) 1.46
Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Arch Gen Psychiatry (2004) 1.44
Quantification of regional ventilation-perfusion ratios with PET. J Nucl Med (2003) 1.42
Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci (2005) 1.39
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Who should read and interpret 18F-FDG PET studies? J Nucl Med (2003) 1.38
A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg (2006) 1.32
PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants. Med Phys (2007) 1.32
Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol Psychiatry (2003) 1.29
CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder. PLoS One (2012) 1.29
Resting metabolic activity in the cingulate cortex and vulnerability to posttraumatic stress disorder. Arch Gen Psychiatry (2009) 1.29
Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One (2010) 1.29
Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol (2008) 1.28
Striatal dopamine release in sequential learning. Neuroimage (2007) 1.25
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry (2007) 1.25
Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol (2005) 1.24
Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med (2005) 1.24
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest (2004) 1.23
Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med (2005) 1.22
Flare response in 18F-fluoride ion PET bone scanning. AJR Am J Roentgenol (2006) 1.21
The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathol (2009) 1.17
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience. Radiology (2006) 1.17
The neural network basis for abnormalities of attention and executive function in major depressive disorder: implications for application of the medical disease model to psychiatric disorders. Harv Rev Psychiatry (2002) 1.16
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol (2005) 1.14
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. Proc Natl Acad Sci U S A (2007) 1.14
In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry (2005) 1.14
Bowel hot spots at PET-CT. Radiographics (2007) 1.14
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2002) 1.10
Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J (2013) 1.09
Differential teratogenic effect of alcohol on embryonic development between C57BL/6 and DBA/2 mice: a new view. Alcohol Clin Exp Res (2005) 1.09
Cerebellar vermis involvement in cocaine-related behaviors. Neuropsychopharmacology (2006) 1.08
Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice. Alcohol Clin Exp Res (2004) 1.08
Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol (2008) 1.08
A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia. Behav Brain Res (2008) 1.07
Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients. AIDS (2009) 1.06
Explicit motor memory activates the striatal dopamine system. Neuroreport (2008) 1.05
Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcohol-preferring rats. Alcohol Clin Exp Res (2006) 1.05
Thimerosal and autism? Pediatrics (2003) 1.05
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord (2012) 1.04
Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med (2004) 1.04
Striatal dopamine release during unrewarded motor task in human volunteers. Neuroreport (2003) 1.03
Dopamine release during human emotional processing. Neuroimage (2009) 1.03
FDG-PET CT for tumor imaging. J Am Coll Radiol (2007) 1.03
Serotonin and its transporter on proliferation of fetal heart cells. Int J Dev Neurosci (2003) 1.03
Density of cerebellar basket and stellate cells in autism: evidence for a late developmental loss of Purkinje cells. J Neurosci Res (2009) 1.02
Cellular epigenetic modifications of neural stem cell differentiation. Cell Transplant (2009) 1.02
Identification of transcription factor and microRNA binding sites in responsible to fetal alcohol syndrome. BMC Genomics (2008) 1.02
Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res Dev Brain Res (2004) 1.02
False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol (2004) 1.01
Effects of burn injury, cold stress and cutaneous wound injury on the morphology and energy metabolism of murine brown adipose tissue (BAT) in vivo. Life Sci (2011) 1.01
Retentive multipotency of adult dorsal root ganglia stem cells. Cell Transplant (2009) 1.01
Strain differences in developmental vulnerability to alcohol exposure via embryo culture in mice. Alcohol Clin Exp Res (2011) 1.01
Iodine-124 as a label for pharmacological PET imaging. Mol Pharm (2011) 1.00